These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16988419)

  • 1. High content translocation assays for pathway profiling.
    Loechel F; Bjørn S; Linde V; Praestegaard M; Pagliaro L
    Methods Mol Biol; 2007; 356():401-14. PubMed ID: 16988419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein translocation assays: key tools for accessing new biological information with high-throughput microscopy.
    Heydorn A; Lundholt BK; Praestegaard M; Pagliaro L
    Methods Enzymol; 2006; 414():513-30. PubMed ID: 17110209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High content screening as a screening tool in drug discovery.
    Nichols A
    Methods Mol Biol; 2007; 356():379-87. PubMed ID: 16988417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.
    Trask OJ; Baker A; Williams RG; Nickischer D; Kandasamy R; Laethem C; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():419-39. PubMed ID: 17110205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent proteins and engineered cell lines.
    Thomas N
    Methods Mol Biol; 2007; 356():165-87. PubMed ID: 16988402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ImmunoCell-Array: a novel technology for pathway discovery and cell profiling.
    Giorgetti L; Zanardi A; Venturini S; Carbone R
    Expert Rev Proteomics; 2007 Oct; 4(5):609-16. PubMed ID: 17941816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
    Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Live-Cell Microarray Technologies.
    Rothbauer M; Ertl P
    Methods Mol Biol; 2018; 1771():3-8. PubMed ID: 29633200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging classes of protein-protein interaction inhibitors and new tools for their development.
    Pagliaro L; Felding J; Audouze K; Nielsen SJ; Terry RB; Krog-Jensen C; Butcher S
    Curr Opin Chem Biol; 2004 Aug; 8(4):442-9. PubMed ID: 15288255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase.
    Brandish PE; Chiu CS; Schneeweis J; Brandon NJ; Leech CL; Kornienko O; Scolnick EM; Strulovici B; Zheng W
    J Biomol Screen; 2006 Aug; 11(5):481-7. PubMed ID: 16760370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors.
    Williams RG; Kandasamy R; Nickischer D; Trask OJ; Laethem C; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():364-89. PubMed ID: 17110203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse-phase protein microarrays for tissue-based analysis.
    Speer R; Wulfkuhle JD; Liotta LA; Petricoin EF
    Curr Opin Mol Ther; 2005 Jun; 7(3):240-5. PubMed ID: 15977421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the integration of immunoreagents and fluorescent probes for multiplexed high content screening assays.
    Giuliano KA
    Methods Mol Biol; 2007; 356():189-93. PubMed ID: 16988403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based microarrays: overview.
    Palmer E
    Methods Mol Biol; 2011; 706():1-12. PubMed ID: 21104050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation Biosensors-Versatile Tools to Probe Protein Functions in Living Cells.
    Fetz V; Stauber RH; Knauer SK
    Methods Mol Biol; 2018; 1683():195-210. PubMed ID: 29082494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-content screening of known G protein-coupled receptors by arrestin translocation.
    Hudson CC; Oakley RH; Sjaastad MD; Loomis CR
    Methods Enzymol; 2006; 414():63-78. PubMed ID: 17110187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking microscopy and high content screening in large-scale biomedical research.
    Evans JG; Matsudaira P
    Methods Mol Biol; 2007; 356():33-8. PubMed ID: 16988393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-content glucocorticoid receptor translocation assay for compound mechanism-of-action evaluation.
    Agler M; Prack M; Zhu Y; Kolb J; Nowak K; Ryseck R; Shen D; Cvijic ME; Somerville J; Nadler S; Chen T
    J Biomol Screen; 2007 Dec; 12(8):1029-41. PubMed ID: 17989426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Translocation Assays to Probe Protease Function and Screen for Inhibitors.
    Hahlbrock A; Gößwein D; Stauber RH
    Methods Mol Biol; 2017; 1574():227-241. PubMed ID: 28315255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell microarrays in drug discovery.
    Castel D; Pitaval A; Debily MA; Gidrol X
    Drug Discov Today; 2006 Jul; 11(13-14):616-22. PubMed ID: 16793530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.